| scholarly article | Q13442814 |
| P2093 | author name string | Feng Qian | |
| Hai-Feng Zhang | |||
| Hai-Bo Zhang | |||
| Wei-Dong Cheng | |||
| Xue-Ping Wu | |||
| Ya-Ling Guo | |||
| P2860 | cites work | The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 |
| The immunopathogenesis of sepsis | Q29622909 | ||
| Novel therapies for septic shock over the past 4 decades | Q33396219 | ||
| Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy | Q33828888 | ||
| The effect of age on the development and outcome of adult sepsis | Q34479183 | ||
| Chitin and Its Effects on Inflammatory and Immune Responses. | Q34552477 | ||
| Sepsis definitions: time for change | Q34649118 | ||
| LPS/TLR4 signal transduction pathway | Q34756268 | ||
| Paroxetine differentially modulates LPS-induced TNFα and IL-6 production in mouse macrophages. | Q35217692 | ||
| HMGB1 is a therapeutic target for sterile inflammation and infection | Q35953553 | ||
| Macrophage complement receptors and pathogen clearance | Q36859212 | ||
| Sepsis, complement and the dysregulated inflammatory response | Q37590899 | ||
| Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury | Q37604884 | ||
| LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway | Q37688762 | ||
| CD169⁺ macrophages provide a niche promoting erythropoiesis under homeostasis and stress | Q37698517 | ||
| Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial | Q38316900 | ||
| Sepsis: a roadmap for future research | Q38453261 | ||
| Vascular endothelial cell Toll-like receptor pathways in sepsis | Q38592310 | ||
| Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses | Q38702398 | ||
| Fisetin inhibits cellular proliferation and induces mitochondria-dependent apoptosis in human gastric cancer cells | Q38766987 | ||
| Post-Translational Modifications of the TAK1-TAB Complex. | Q39096576 | ||
| Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization. | Q39099628 | ||
| Stercurensin inhibits nuclear factor-κB-dependent inflammatory signals through attenuation of TAK1-TAB1 complex formation | Q39602471 | ||
| p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection | Q41355717 | ||
| Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis | Q45895881 | ||
| Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells | Q46248167 | ||
| Fisetin as a caloric restriction mimetic protects rat brain against aging induced oxidative stress, apoptosis and neurodegeneration | Q47622689 | ||
| MK2 balances inflammation and cell death | Q47727789 | ||
| TAK1 adaptor proteins, TAB2 and TAB3, link the signalosome to B-cell receptor-induced IKK activation | Q48124315 | ||
| TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis | Q48641496 | ||
| Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. | Q51241980 | ||
| Macrophages and the Recovery from Acute and Chronic Inflammation. | Q51270292 | ||
| Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways. | Q51415249 | ||
| Targeting macrophage immunometabolism: Dawn in the darkness of sepsis. | Q52602147 | ||
| Fisetin Exerts Antioxidant and Neuroprotective Effects in Multiple Mutant hSOD1 Models of Amyotrophic Lateral Sclerosis by Activating ERK. | Q52646216 | ||
| Anti-septic effects of fisetin in vitro and in vivo. | Q52649154 | ||
| MK2 mediates macrophage activation and acute lung injury by regulating let-7e miRNA. | Q54109229 | ||
| Curcumin's Metabolites, Tetrahydrocurcumin and Octahydrocurcumin, Possess Superior Anti-inflammatory Effects Through Suppression of TAK1-NF-κB Pathway | Q58606486 | ||
| Fisetin inhibits the generation of inflammatory mediators in interleukin-1β–induced human lung epithelial cells by suppressing the NF-κB and ERK1/2 pathways | Q58674403 | ||
| Nrf2⁻ARE Signaling Acts as Master Pathway for the Cellular Antioxidant Activity of Fisetin | Q64260068 | ||
| Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalph | Q80043880 | ||
| Regulated cell death and inflammation: an auto-amplification loop causes organ failure | Q85817618 | ||
| Costunolide alleviates HKSA-induced acute lung injury via inhibition of macrophage activation | Q91050096 | ||
| Intracellular synthesis of gold nanoparticles by Gluconacetobacter liquefaciens for delivery of peptide CopA3 and ginsenoside and anti-inflammatory effect on lipopolysaccharide-activated macrophages | Q92057185 | ||
| α-Mangostin suppresses NLRP3 inflammasome activation via promoting autophagy in LPS-stimulated murine macrophages and protects against CLP-induced sepsis in mice | Q92709750 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | fisetin | Q418384 |
| P577 | publication date | 2020-07-13 | |
| P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
| P1476 | title | Fisetin alleviates sepsis-induced multiple organ dysfunction in mice via inhibiting p38 MAPK/MK2 signaling |
Search more.